Mid-Year Milestones

For Houlihan Lokey’s Global Healthcare Group

Houlihan Lokey’s Healthcare Group is pleased to highlight the recent accomplishments of its global team.

In 2024, our Healthcare Group was ranked the No. 1 M&A advisor for global healthcare transactions under $1 billion. We provide deep insights, a proven track record, and an exceptional level of service to our clients. Our team has earned a reputation for delivering superior outcomes across M&A advisory, capital raising, restructuring, and financial and valuation advisory services.

We have extensive relationships with both public and private strategic and financial sponsors, enabling us to provide valuable, timely advice to allow our clients to achieve their objectives.

Click on each tombstone below for details on transactions from Houlihan Lokey’s Global Healthcare Group.

News and Insights From Our Firm’s Thought Leaders

Outsourced Orthopedic and Medical Metal Manufacturing Segment Spotlight

Our Q3 2025 Spotlight on Outsourced Orthopedic and Medical Metal Manufacturing highlights key trends driving steady growth in the orthopedic device outsourcing market, following post-COVID-19 slowdowns and inventory adjustments. Click here to read the report.

Healthcare Technology: GRC and Workforce Management

Healthcare Technology Market Update | GRC and Workforce Management

Our April 2025 edition of the Healthcare Technology Market Update offers valuable insights into governance, risk, and compliance and workforce management in the healthcare sector. Click here to read the report.

Primary Care Sector Spotlight

Our Spring 2025 edition of the Primary Care Sector Spotlight provides timely insights into evolving investment trends, innovative care models, and strategic growth opportunities in frontline healthcare. Click here to read the report.

Pharma Commercialization Market Update

Our 2H 2024 edition of the Pharma Commercialization Market Update features key transaction announcements, public market trends, and strategic insights into the evolving pharmaceutical landscape. Click here to read the report.

Contacts

For more information on our services or to discuss how we can help advance your vision, please contact one of the individuals listed below.

Mark Francis
Managing Director
Global Co-Head of Healthcare

+1 214.220.8484
Email

Michael Pisani
Managing Director
Global Co-Head of Healthcare

+1 214.665.8611
Email

U.S. Contacts

Dudley Baker
Managing Director

Keith Barry
Managing Director
Head of Medical Technology

Jerome (J.J.) Brown
Managing Director

Luiz Greca
Managing Director

Jon Guskind
Managing Director

Erik Kistler
Managing Director

Trey Marinello
Managing Director

Mark Martin
Managing Director
Global Head of Pharma Services

Kerr Robertson
Managing Director

Matthew Ryan
Managing Director
Head of Healthcare Services

EMEA Contacts

Paul Tomasic
Managing Director
Head of European Healthcare

+44 20 7747 6673
Email

Daniel Fritz
Managing Director

+41 79 696 06 67
Email

Rainer Hepberger
Managing Director

+44 20 7907 4224
Email

APAC Contacts

Christian Lunny
Managing Director

+61 403 551 281
Email

Takashi Misato
Managing Director

+81 80 9027 3013
Email

About Houlihan Lokey

Houlihan Lokey, Inc. (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital solutions, financial restructuring, and financial and valuation advisory. Houlihan Lokey serves corporations, institutions, and governments worldwide with offices in the Americas, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firm’s commitment to client success across its advisory services. The firm is the No. 1 investment bank for all global M&A transactions for the past two years, the No. 1 M&A advisor for the past 10 years in the U.S., the No. 1 global restructuring advisor for the past 11 years, and the No. 1 global M&A fairness opinion advisor over the past 25 years, all based on number of transactions and according to data provided by LSEG.